| Human ENPP-3 (558-875) Protein (LTP10214) |
| LTP10214 |
| 100ug |
|
$473 In stock |
| Ectonucleotide pyrophosphatase-phosphodiesterase 3 (ENPP3), a protein detected in the human uterus, has been found to play an important role in the development and invasion of tumours. It was recently discovered that ENPP3 was upregulated during the window of implantation in the human endometrium but its functional relevance remains elusive. |
| Recombinant Human ENPP-3(558-875) Protein is expressed from Expi293 with His tag at the N-terminal. It contains Lys558-Ile875. |
| ENPP-3 |
| Human |
| O14638 |
| Lys558-Ile875 |
| The protein has a predicted MW of 39.06 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on the Tris-Bis PAGE result. |
| 0 |
| N-His |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| ![Human ENPP-3 (558-875) Protein (LTP10214)](/peptide-product/images/protein-products/LTP10214/20211201160834.png) |